Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2009, ending September 27, 2008, on Wednesday, October 29, 2008 after the market
Toggle Summary First CyberKnife in Saudi Arabia to be Installed at Prestigious King Faisal Specialist Hospital and Research Center
SUNNYVALE, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first CyberKnife(R) Robotic Radiosurgery System in the Kingdom of Saudi Arabia will be installed at the prestigious King Faisal Specialist
Toggle Summary Accuray Management to Speak at Natixis Bleichroeder Annual 'Hidden Gems' Conference
SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Natixis Bleichroeder Annual "Hidden Gems" Conference in New York on Monday, October 13, 2008 at
Toggle Summary Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology
Advancements in Treatment Planning and Delivery Enable CyberKnife Centers to Fulfill Increasing Demand for Radiosurgery SUNNYVALE, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Oklahoma CyberKnife
Toggle Summary Accuray Introduces the InTempo(TM) Adaptive Imaging System to Address Prostate Motion That Commonly Occurs During Radiation Treatment Delivery
New Capabilities Help to Ensure Prescribed Dose is Delivered to the Prostate While Precisely Controlling Exposure to Surrounding Healthy Tissue SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today introduced
Toggle Summary Accuray Licenses Technology From Morphormics for Prostate Cancer Treatment Planning
Investment Confirms Company's Commitment to Improving Ability to Treat Prostate SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with Morphormics Incorporated, a
Toggle Summary Accuray Launches New Configuration for CyberKnife System to Offer Hospitals Installation Flexibility
New Footprint Enables Hospitals to Save Construction Costs and Speed Deployment Time by Placing CyberKnife System in Existing Vault SUNNYVALE, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it is
Toggle Summary Accuray Incorporated and IMPAC Medical Systems to Link CyberKnife(R) Robotic Radiosurgery System with MOSAIQ(R) EMR
Partnership underscores widespread adoption of the CyberKnife System and IMPAC's commitment to vendor independent connectivity SUNNYVALE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY) and IMPAC Medical Systems, Inc. announced today that they will collaborate to
Toggle Summary Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the UBS Global Life Sciences Conference in New
Toggle Summary Accuray Incorporated Announces Resignation of Chief Financial Officer
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Robert E. McNamara has resigned as chief financial officer and senior vice president to pursue other interests.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.